CVS GROUP PLC

Transaction in Own Shares • Nov 17, 2025

National Storage Mechanism | Additional information

RNS Number : 6870H

CVS Group plc

17 November 2025

17 November 2025

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

CVS announces that on 14 November 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

Date of purchase:	14/11/2025
Aggregate number of Ordinary Shares purchased:	26,396
Lowest price paid per share (GBp):	1,128.00
Highest price paid per share (GBp):	1,148.00
Volume weighted average price paid per share (GBp):	1,136.24

CVS intends to cancel all of the purchased Ordinary Shares.

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 71,316,491 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

The total number of voting rights in CVS is therefore 71,316,491 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

Since the commencement of the Share Buyback Programme, the Company has repurchased 424,292 Ordinary Shares in aggregate at a weighted average price of 1,244.89 pence per share.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

Individual transactions:

Number of Ordinary Shares purchased	Transaction price (GBp share)	Time of transaction (UK Time)	Transaction reference number	Trading Venue
215	1134	14/11/2025 08:00:40	1332909357140974	XLON
273	1130	14/11/2025 08:03:45	1332909357142614	XLON
86	1128	14/11/2025 08:08:32	1332909357144639	XLON
13	1128	14/11/2025 08:08:32	1332909357144640	XLON
85	1128	14/11/2025 08:08:42	1332909357144672	XLON
76	1128	14/11/2025 08:15:52	1332909357147470	XLON
444	1132	14/11/2025 08:26:10	1332909357149407	XLON
76	1132	14/11/2025 08:31:28	1332909357150332	XLON
376	1134	14/11/2025 08:44:55	1332909357153622	XLON
422	1134	14/11/2025 08:44:55	1332909357153623	XLON
80	1134	14/11/2025 08:45:38	1332909357153808	XLON
39	1132	14/11/2025 08:51:00	1332909357154736	XLON
805	1132	14/11/2025 08:51:00	1332909357154737	XLON
76	1132	14/11/2025 08:52:15	1332909357154866	XLON
743	1132	14/11/2025 09:01:35	1332909357156233	XLON
149	1132	14/11/2025 09:01:35	1332909357156234	XLON
275	1132	14/11/2025 09:09:23	1332909357157451	XLON
478	1132	14/11/2025 09:09:23	1332909357157452	XLON
1136	1136	14/11/2025 09:44:10	1332909357162081	XLON
712	1136	14/11/2025 09:44:10	1332909357162082	XLON
225	1136	14/11/2025 09:44:10	1332909357162083	XLON
136	1136	14/11/2025 09:59:59	1332909357163662	XLON
314	1134	14/11/2025 10:18:17	1332909357165692	XLON
198	1134	14/11/2025 10:18:17	1332909357165695	XLON
76	1132	14/11/2025 10:41:43	1332909357168657	XLON
348	1130	14/11/2025 11:00:12	1332909357170872	XLON
239	1130	14/11/2025 11:00:12	1332909357170873	XLON
952	1130	14/11/2025 11:21:51	1332909357173620	XLON
2	1130	14/11/2025 11:21:52	1332909357173629	XLON
658	1130	14/11/2025 11:42:02	1332909357175641	XLON
634	1130	14/11/2025 11:42:02	1332909357175642	XLON
17	1128	14/11/2025 11:42:19	1332909357175675	XLON
16	1128	14/11/2025 11:42:46	1332909357175729	XLON
608	1128	14/11/2025 11:47:09	1332909357176433	XLON
1212	1136	14/11/2025 12:53:43	1332909357183918	XLON
470	1136	14/11/2025 12:53:43	1332909357183920	XLON
252	1138	14/11/2025 12:58:49	1332909357184498	XLON
1300	1136	14/11/2025 13:10:47	1332909357185797	XLON
1308	1136	14/11/2025 13:10:47	1332909357185798	XLON
709	1138	14/11/2025 13:40:04	1332909357188584	XLON
1320	1140	14/11/2025 13:49:27	1332909357189886	XLON
968	1140	14/11/2025 13:49:29	1332909357189898	XLON
200	1148	14/11/2025 13:52:58	1332909357190417	XLON
982	1146	14/11/2025 13:54:32	1332909357190590	XLON
275	1146	14/11/2025 13:54:33	1332909357190591	XLON
76	1144	14/11/2025 13:57:33	1332909357190905	XLON
234	1144	14/11/2025 13:57:33	1332909357190906	XLON
341	1138	14/11/2025 14:10:15	1332909357192775	XLON
197	1138	14/11/2025 14:10:15	1332909357192777	XLON
268	1136	14/11/2025 14:26:40	1332909357194556	XLON
306	1136	14/11/2025 14:30:55	1332909357195586	XLON
100	1136	14/11/2025 14:30:55	1332909357195608	XLON
501	1136	14/11/2025 14:30:55	1332909357195609	XLON
1341	1138	14/11/2025 14:39:43	1332909357197915	XLON
622	1138	14/11/2025 14:39:43	1332909357197916	XLON
100	1138	14/11/2025 14:39:43	1332909357197917	XLON
68	1138	14/11/2025 14:39:43	1332909357197918	XLON
24	1138	14/11/2025 14:39:43	1332909357197919	XLON
784	1138	14/11/2025 14:40:04	1332909357198014	XLON
60	1138	14/11/2025 14:40:04	1332909357198015	XLON
360	1142	14/11/2025 15:07:18	1332909357204815	XLON
556	1144	14/11/2025 15:08:40	1332909357205115	XLON
480	1148	14/11/2025 15:18:38	1332909357207301	XLON

Contacts

CVS Group plc                                                                                                           via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

Berenberg (Joint Broker)                                                                                             +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

Camarco (Financial PR)                                                                                             [email protected]

Ginny Pulbrook                                                                                                             +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSGPGGPGUPAGBC